Representatives from 26 OAS member states finalized an overhaul of the Multilateral Evaluation Mechanism (MEM) instrument used to assess member states' drug policies. The changes update the MEM to align it with the 2010 Hemispheric Drug Strategy and its 2011-2015 Plan of Action. The Inter-Governmental Working Group meeting sought to recast the evaluation process within this framework and improve the Mechanism. They developed a survey of 27 policy recommendations focused on institutional strengthening, demand reduction, supply reduction, control measures, and international cooperation. The results will provide feedback to countries on their progress fulfilling the recommendations. The updated MEM documents will be submitted for approval at the next CICAD commission meeting in November.